BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen L, Qu J, Kalyani FS, Zhang Q, Fan L, Fang Y, Li Y, Xiang C. Mesenchymal stem cell-based treatments for COVID-19: status and future perspectives for clinical applications. Cell Mol Life Sci 2022;79. [DOI: 10.1007/s00018-021-04096-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Reza Samanipour, Sara Tabatabaee, Mahsa delyanee, Amirhossein Tavakoli. The promising approach of MSCs therapy for COVID-19 treatment. Cell Tissue Bank 2022. [PMID: 36526819 DOI: 10.1007/s10561-022-10060-2] [Reference Citation Analysis]
2 Kiselevskiy MV, Treshalina HM, Mikhailova IN, Martirosyan DV, Manina IV, Reshetnikova VV, Kozlov IG. Opportunities for correction of immunosuppression in patients with COVID-19. Russian Journal of Infection and Immunity 2022;12:651-658. [DOI: 10.15789/2220-7619-ofc-1917] [Reference Citation Analysis]
3 Huang Y, Li X, Yang L. Mesenchymal stem cells and their derived small extracellular vesicles for COVID-19 treatment. Stem Cell Res Ther 2022;13:410. [PMID: 35962458 DOI: 10.1186/s13287-022-03034-4] [Reference Citation Analysis]
4 Hoang DM, Pham PT, Bach TQ, Ngo ATL, Nguyen QT, Phan TTK, Nguyen GH, Le PTT, Hoang VT, Forsyth NR, Heke M, Nguyen LT. Stem cell-based therapy for human diseases. Signal Transduct Target Ther 2022;7:272. [PMID: 35933430 DOI: 10.1038/s41392-022-01134-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Chaudhary JK, Saini D, Chaudhary PK, Maurya A, Verma GK, Gupta AK, Roshan R, Vats TK, Garg N, Yadav D, Kant N, Meena AK, Mirza-shariff AA. Exploring the Immunomodulatory Aspect of Mesenchymal Stem Cells for Treatment of Severe Coronavirus Disease 19. Cells 2022;11:2175. [DOI: 10.3390/cells11142175] [Cited by in F6Publishing: 1] [Reference Citation Analysis]